Stock 301331 ENWEI PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Enwei Pharmaceutical Co., Ltd.

Equities

301331

CNE100005LC7

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 03:30:00 31/05/2024 am IST 		5-day change 1st Jan Change
26.81 CNY +1.59% Intraday chart for Enwei Pharmaceutical Co., Ltd. +0.22% -4.41%
21/04 Enwei Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
02/04 Tranche Update on Enwei Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on October 21, 2023. CI

Business Summary

Enwei Pharmaceutical Co Ltd is a China-based company mainly engaged in the research, development, production and sales of proprietary Chinese medicines and chemical medicines. The Company focuses on gynecological products, pediatric medicines, respiratory medicines and other fields. The Company's main products include Jieeryin lotion, Jieeryin ointment, Jieeryin effervescent tablets, Shanmai Jianpi oral liquid, Qingjing capsules and Danxiong Tongmai granules. Its products are mainly sold through direct sales and e-commerce. The Company principally conducts its businesses in the domestic market.

Number of employees: 1,552

Sales per Business

CNY in Million2022Weight2023Weight Delta
Gynecology
46.2 %
353 51.0 % 363 46.2 % +2.80%
Cold
20.5 %
131 18.9 % 161 20.5 % +22.73%
Other Classes
20.2 %
117 16.9 % 158 20.2 % +35.26%
Pediatrics
12.7 %
87 12.6 % 100 12.7 % +14.77%
Rent
0.5 %
4 0.6 % 4 0.5 % -2.09%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
100.0 %
692 100.0 % 785 100.0 % +13.54%

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 103,940,521 26,334,707 ( 25.34 %) 1,048,634 ( 1.009 %) 25.34 %

Shareholders

NameEquities%Valuation
Golden Trust Sinopac Fund Management Co., Ltd.
0.5878 %
135,100 0.5878 % 769 948 ¥
Hui'an Fund Management Co. Ltd.
0.1958 %
45,000 0.1958 % 256 460 ¥
China Asset Management Co., Ltd.
0.0348 %
8,000 0.0348 % 45 593 ¥
CCB Principal Asset Management Co., Ltd.
0.0174 %
4,000 0.0174 % 22 796 ¥
Hwabao WP Fund Management Co., Ltd.
0.0122 %
2,800 0.0122 % 15 957 ¥
Guotai Asset Management Co., Ltd.
0.000435 %
100 0.000435 % 570 ¥

Company contact information

Enwei Pharmaceutical Co., Ltd.

Enwei Building, Chuangye Avenue Dam A Area

854000, Changdu

+

http://www.enwei.com.cn
address Enwei Pharmaceutical Co., Ltd.(301331)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sector Other Pharmaceuticals

1st Jan change Capi.
ENWEI PHARMACEUTICAL CO., LTD. Stock Enwei Pharmaceutical Co., Ltd.
-4.41% 37Cr
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+40.73% 74TCr
NOVO NORDISK A/S Stock Novo Nordisk A/S
+32.83% 60TCr
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.42% 35TCr
MERCK & CO., INC. Stock Merck & Co., Inc.
+15.15% 32TCr
ABBVIE INC. Stock AbbVie Inc.
+4.05% 28TCr
ASTRAZENECA PLC Stock AstraZeneca PLC
+15.00% 24TCr
ROCHE HOLDING AG Stock Roche Holding AG
-5.52% 21TCr
AMGEN INC. Stock Amgen Inc.
+6.19% 16TCr
PFIZER, INC. Stock Pfizer, Inc.
-0.45% 16TCr
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 301331 Stock
  4. Company Enwei Pharmaceutical Co., Ltd.